Valuation: Rani Therapeutics Holdings, Inc.

Market Cap 68.66M 60.15M 55.46M 51.25M 97.17M 6.55B 98.79M 663M 260M 3.23B 258M 252M 11.1B P/E 2026 *
-3.68x
P/E 2027 * -3.17x
Enterprise Value 68.66M 60.15M 55.46M 51.25M 97.17M 6.55B 98.79M 663M 260M 3.23B 258M 252M 11.1B EV / Sales 2026 *
16.6x
EV / Sales 2027 * 13.9x
Free-Float
78.3%
Yield 2026 *
-
Yield 2027 * -
1 day-1.58%
1 week-10.90%
Current month-9.63%
1 month-12.23%
3 months-7.14%
6 months-50.91%
Current year-49.10%
1 week 0.66
Extreme 0.66
0.83
1 month 0.66
Extreme 0.66
0.83
Current year 0.66
Extreme 0.66
1.54
1 year 0.39
Extreme 0.387
3.87
3 years 0.39
Extreme 0.387
8.75
5 years 0.39
Extreme 0.387
36.27
10 years 0.39
Extreme 0.387
36.27
Manager TitleAgeSince
Chief Executive Officer 45 01/06/2021
Director of Finance/CFO 46 29/06/2026
Chief Tech/Sci/R&D Officer 42 01/01/2022
Director TitleAgeSince
Chairman 69 01/06/2021
Director/Board Member 80 01/09/2018
Director/Board Member 69 06/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-03Free

Executive/Senior Manager

805,500 0.8077%
06-03Free

Chief Technology Officer

805,500 0.8077%
06-03Free

Founder

3,800,000 3.8106%
Change 5-day change 1-year change 3-year change Capi.($)
-1.58%-10.90%+4.07%-84.45% 68.66M
-4.14%-8.06%+57.35%+117.24% 54.63B
+1.84%-0.66%+75.79%+93.87% 54.88B
-2.24%+3.59%+19.60%+466.72% 25.06B
-1.60%-6.21%-19.69%-14.84% 23.14B
+2.43%+1.06%+47.70%-0.11% 19.88B
-3.19%0.00%+33.99%-26.87% 17.55B
-6.84%+2.18%+195.12%+357.18% 16.5B
-1.05%+1.16%+25.08%+196.28% 14.2B
+8.74%+3.51%+53.81% - 15.36B
Average -0.76%-1.34%+49.28%+122.78% 24.13B
Weighted average by Cap. -0.91%-1.46%+55.03%+137.72%

Financials

2026 *2027 *
Net sales 4.13M 3.62M 3.33M 3.08M 5.84M 394M 5.94M 39.83M 15.62M 194M 15.5M 15.16M 667M 4.92M 4.31M 3.98M 3.68M 6.97M 470M 7.09M 47.53M 18.64M 231M 18.49M 18.09M 796M
Net income -33.21M -29.1M -26.83M -24.79M -47.01M -3.17B -47.79M -321M -126M -1.56B -125M -122M -5.37B -39.93M -34.98M -32.25M -29.8M -56.51M -3.81B -57.45M -385M -151M -1.88B -150M -147M -6.46B
Net Debt - -
Logo Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).
Employees
70
Date Price Change Volume
10/07/26 $0.6872 -1.58% 798,352
09/07/26 $0.6982 +0.75% 603,296
08/07/26 $0.6930 -2.30% 631,725
07/07/26 $0.7093 -10.55% 1,579,084
06/07/26 $0.7930 +2.81% 950,800
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.6872USD
Average target price
7.500USD
Spread / Average Target
+991.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RANI Stock